Hexapeptide-9 (Hexapeptide-9, inoa kālepa ʻo Collaxyl™) he peptide bioactive synthetic i hana ʻia me ʻeono mau waikawa amino kikoʻī. Loaʻa ke ʻano pololei o kēia peptide i loko o ka collagen kanaka IV a me XVII; pili loa kēia mau mea me nā mea nui o ka membrane lalo o ka ʻili. Hoʻohui ʻia ʻo Biotechnologically e hoʻohālike i kekahi, ina aole pau, nā hana o ka collagen maoli, maʻemaʻe a me ka paʻa pilikia inhered in oi 'kuʻuna’ hoʻopau ʻia nā mea ʻili maoli. ʻO ke kūpaʻa kiʻekiʻe a me ka maʻalahi o ka hoʻokumu ʻana ua alakaʻi i kona hoʻohana ʻana i ke ao holoʻokoʻa i nā huahana skincare anti-aging.
Kaʻina
Gly-Pro-Gln-Gly-Pro-Gln
Helu CAS
1228371-11-6
ʻĀpana Molekala
C₂₄H₃₈N₈O₉
Kaumaha Molekala
582.28 g/mol
Noiʻi o Hexapeptide-9
Hoʻopaʻa ʻia nā ʻano hana he nui no Hexapeptide-9. Hoʻohana ʻia kahi ʻano mua o ka memo biological – ho'āla a hoʻoponopono i nā ala hoʻoponopono o ka ʻili.
Hoʻolaha ʻia ʻo Collagen Synthesis: ʻO ka hoʻoulu pololei ʻana i nā fibroblasts dermal kekahi o ia ʻano hana; ʻO ka hoʻonui ʻana i ka hana o Type I a me Type IV collagen ka hopena hopena. ʻO ke ʻano I lawelawe ma ke ʻano he kākoʻo hoʻolālā mau i loaʻa i loko o ka dermis, ʻo ke kūpaʻa ʻana he huahana pololei. ʻAno IV (ka 'collagen pēpē’ inā makemake ʻoe) pili i ka elasticity a me ka laumania maʻamau i ka ʻili.
ʻO ka hoʻokiʻekiʻe like ʻana o kēia mau collagens ʻelua e alakaʻi i ka hoʻoponopono hou ʻana o ka papa hana dermal lalo., e hoʻemi ana i ka hohonu o ka wrinkle a me ka hoʻomaikaʻi ʻana a puni i ka paʻa.
Ka hooikaika ana ka Hui Dermal-Epidermal(WAI): ʻO kēia kahi i hoʻokaʻawale maoli ai ʻo Hexapeptide-9 iā ia iho. ʻO ka DEJ (hou, he alahaka kino) ua hoʻihoʻi hapa ʻia e ia. ʻO Laminin-5 a me Type IV collagen synthesis i loko o kēia wahi ka mea e waiwai nui ai ʻo Hexapeptide-9 i ka mea hoʻohana hope..
Ka hoʻoili ʻana i ka meaʻai, ka hoʻonohonoho pono a me nā mea a pau e pili ana, he paio mau i ka manawa a me ka sagging.
Hoʻonui i ka Paʻi ʻili a me ka Hydration: Ma waho aʻe o kāna mau hana dermal, ʻO Hexapeptide-9 ka wikiwiki i nā kaʻina hana hoʻoponopono epidermal. Hoʻihoʻi hou i ka ʻili i pōʻino (hōʻailona post-acne, nā ʻano ʻōpala like ʻole, a i ʻole kekahi mau hopena kaʻina hana post-aesthetic) ʻo ia kekahi o kāna mau noi waiwai.
Ua hōʻike ʻia kahi haʻawina in vitro efficacy i ka upregulation o ka filaggrin (FLG) gene; ʻO ka hoʻokaʻawale ʻana o ka epidermal a ma hope o ka hana pale e hilinaʻi nui i kēia protein. ʻO Filaggrin ponoʻī kahi mea mua i ka mea i kapa ʻia ʻo Natural Moisturizing Factors – ʻO ka hoʻonui ʻia ʻana he hōʻailona pololei o ka hydration ʻili no ka wā pōkole a lōʻihi, kahi kokoke kūpono loa o ka pale pale.
Ua hōʻike ʻia nā haʻawina lāʻau lapaʻau i ka piʻi ʻana o ka hana collagen holoʻokoʻa (a hiki i 117% ke hoomanao pololei) a ʻoi aku ka maʻalahi akā hiki ke ana ʻia i ka elasticity.
Eia kekahi, Ke kuhikuhi nei ka noiʻi i ka cyclic hexapeptide-9 (CHP-9) ma ke ʻano he ʻoi aku ka maikaʻi o ka anti-aging solution. Loaʻa i nā peptides laina kuʻuna ko lākou wahi, akā, hāʻawi ka ʻōnaehana cyclic i ka paʻa, hoʻonui i ka bioavailability a me nā hana physiological āpau.
ʻO ka noi kumuhana o kekahi ʻano o kēia cyclic peptide he laina manaʻo maikaʻi loa ia e pale ai a i ʻole e hoʻolōʻihi i ka ʻelemakule o ka ʻili.. ʻO ka hōʻoia ʻana i nā pōmaikaʻi āpau i ʻōlelo ʻia ma o nā haʻawina hoʻomalu kūpono ʻo ia ka hana kūpono aʻe.
COA
HPLC
MS





